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 Nowadays, dysfunction or imbalance of lipid metabolism is believed as the cause 
of many lifestyle related diseases, such as obesity, fatty liver and atherosclerosis. These 
diseases consequently are the main risk factors of cardiovascular disease (CVD) which is 
the leading cause of mortality worldwide. The prevalence of CVD has not increased only 
in the elder, but also in the midlife and the young adulthood due to the changes of the 
lifestyle in our societies. Hence, the improvement of lipid metabolism is essential to 
prevent or ameliorate many diseases. One of the most important factors that are 
concerned as the therapeutic target of CVD is triacylglycerol (TG). 
TG is a dense form in which to store the energy. It circulates in the plasma in 
lipoproteins and also presents as lipid droplets within cells. Most tissues are involved in 
TG metabolism, but adipose tissue, skeletal muscle and liver are quantitatively more 
important than other tissues. In the case of adipose tissue, adipocyte hypertrophy 
results in elevated TG storage, primarily contributes to the development of obesity. 
Whereas in the liver fatty acids were re-esterified within the endoplasmic reticulum 
(ER) to produce TG that will be secreted as very-low-density lipoprotein (VLDL). 
Therefore, ameliorating the dysfunctions of lipid metabolism in the adipose tissue and 
the liver is essential to abate diverse lifestyle related diseases, particularly CVD. 
Generally, diet from marine source shows many benefits for health. Omega-3 
polyunsaturated fatty acids (PUFAs), especially eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) from marine sources, have been developed commercially as 
dietary supplements due to their various health benefits, particularly their hypolidemic 
and anti-obesity effects. EPA has TG-reducing effects in normolipidemic and in 
hyperlipidemic subjects. However, EPA in the diet is easily oxidized at room 
temperature and several types of oxidized EPA (OEPA) derivatives are generated. It has 
been proposed that oxidation products of omega-3 fatty acids, especially EPA and DHA, 
play crucial roles in the palliative effects via many mechanisms particularly those that 
are cardiovascular-related.  
On the other hand, some PUFAs, such as linoleic acid (LA) and linolenic acid 
(LNA), cannot suppress hepatic lipogenesis and TG accumulation in mouse adipocytes 
(3T3-L1). Notwithstanding, it is suspicious that their oxygenated forms might involve in 
many benefits in our health. Recently, Ogawa et al. discovered many species of 
intermediates from the metabolic pathway of gut bacterium Lactobacillus plantarum, 
which are hydroxy-fatty acids, oxo-fatty acids, conjugated fatty acids, and partially fatty 
acids. These new-finding fatty acids were predicted to exert their physiological functions, 
especially the improvement in lipid metabolism. 
The aims of this study were to examine the properties and bioactivities of 
oxygenated fatty acids from various sources, including the autoxidation of EPA and the 
fermentation from L. plantarum, on lipid metabolism in human hepatocellular liver 
carcinoma cell line (HepG2), 3T3-L1 preadipocytes and diabetic KK-Ay mice fed with 
high fat diet. In this study, for the first time the ameliorating effects of OEPA and 
oxygenated fatty acids from L. plantarum fermentation on TG accumulation were 
investigated. The importances of this study are not only the preferable effects on lipid 
metabolism of oxygenated fatty acids from marine sources compared to their intact form, 
but the data also suggested that the efficiency of each oxygenated fatty acid depends on 
the chemical structure, particularly the type, the location and the number of functional 
group and double bond. 
Chapter 1: Oxidized EPAs (OEPAs) more potently suppress 
lipogenesis in hepatocytes than its intact form 
INTRODUCTION 
CVD is the leading cause of mortality worldwide. TG, in either the serum or the 
liver, is a major risk factor for CVD. With respect to the importance of hepatic TG levels, 
nonalcoholic fatty liver disease (NAFLD) is highly associated with CVD. Several 
prospective epidemiological studies recently demonstrated that both an increased liver 
enzyme concentration in the serum and hepatic steatosis determined by ultrasound are 
able to predict the development of CVD independent of alcohol consumption or 
traditional CVD risk markers, such as serum LDL cholesterol concentrations. In 
addition, Rijzewijk et al. demonstrated that type 2 diabetes mellitus patients with high 
liver TG content showed a decreased myocardial perfusion compared with similar 
diabetes patients with low liver TG content.  Therefore, the dysfunction of hepatic lipid 
metabolism has been of concern as a therapeutic target of CVD. 
Omega-3 PUFAs, especially EPA, have been developed commercially as dietary 
supplements due to their various health benefits, particularly their ameliorating effect 
on CVD [11, 12]. EPA has TG-reducing effects in normolipidemic and in hyperlipidemic 
subjects . It has been proposed that EPA decreases TG through the regulation of 
peroxisome proliferator-activated receptor α (PPARα) and sterol regulatory element-
binding protein (SREBP)-1, which govern hepatic fatty acid (FA) catabolism and 
synthesis, respectively.  
Oxidation products of omega-3 fatty acids, especially EPA and DHA, play crucial 
roles in the palliative effects via many mechanisms especially those that are 
cardiovascular-related. A study by Majkova et al. showed that components of oxidized 
docosahexaenoic acid (DHA) can alleviate the endothelial dysfunction caused by 
coplanar PCB77. Furthermore, oxidized EPA (OEPA) has been shown to inhibit 
leukocyte-endothelial interactions by potently activating PPARα in endothelial cells, and 
to do so to a much greater extent than native EPA. Although native EPA activates 
PPARα about half as well as OEPA, unlike EPA, OEPA has effects on leukocyte-
endothelial interactions in vitro and in vivo. 5-HEPE, a metabolite produced from EPA 
in human neutrophils and eosinophils, has been shown to be a potent agonist for G 
protein-coupled receptor (GPR) 119, which results in a reduction in food intake and in 
body weight gain in rats, and to enhance glucose-dependent insulin secretion. 
However, the effects of OEPA on many processes are still obscure. Therefore, the 
aim of this study is to elucidate the mechanism of 4-24 h OEPAs which are composed of 
various species of oxidation products on lipid metabolism, particularly via the LXRα and 
SREBP-1c pathway, which plays an important role in lipid metabolism in liver cells. 
Surprisingly, the result shows that OEPA significantly down-regulates the expression of 
lipogenic genes, which results in the suppression of hepatocellular TG more than EPA. 
MATERIALS AND METHODS 
OEPAs, prepared by incubation in a 40°C water bath for 4-24 h, were analyzed to 
characterize their derivatives by LC-MS and then treated to human hepatocellular liver 
carcinoma cell line (HepG2) with T0901317, synthetic LXR agonist. Cell viability was 
determined by WST-1 assay. The mRNA expression levels of sterol-regulatory element 
binding protein-1c (SREBP-1c), stearoyl-coenzyme A desaturase-1 (SCD-1), fatty acid 
synthase (FAS), acetyl-CoA carboxylase (ACC1), glycerol-3-phosphate acyltransferase 
(GPA) and peroxisome proliferator-activated receptor γ co-activator 1β (PGC-1β) were 
evaluated by real-time RT-PCR. The precursor and mature forms of SREBP-1 protein 
were examined by western blot analysis. Cellular TG accumulation was assayed by 





































I. Changes in derivatives of EPA oxidation products after autoxidation  
First, OEPAs were prepared from EPA (10 mg) by autoxidation. [M-H]- at the 
mass to charge ratio (m/z) 301.2 presented as the molecular ion of EPA and m/z 317.2-
397.2 were presumably derived from EPA oxidation products. The intensity of the 
molecular ion of EPA at m/z 301.2 decreased continuously after autoxidation. After 
oxidation for 4 h, several new ions that were oxidative products of EPA appeared. The 
molecular ion [M-H]- of hydroxy-EPA (HEPE) at m/z 317.2 reached a peak at 4 h 
incubation and then gradually decreased. HEPE was the major EPA oxidation product 
at 4 and 8 h. On the other hand, the ion at m/z 349.2 was detected at 8 h and after that 
it reduced gradually. The ions at m/z 333.2, 365.2 and 397.2 were found at 4, 4 and 8 h, 











Figure 1. Ion intensities derived from EPA and EPA oxidation products analyzed by 
LC/MS. m/z 301.2 was derived from EPA and m/z 317.2-397.2 were presumably derived 
from hydroxy- and hydroperoxy-EPAs. Each oxidized EPA was prepared from EPA (10 
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II. Effects of each fatty acid on HepG2 cell viability 
Various concentrations of fatty acids and T0901317 were added to HepG2 liver 
cells in culture. Figure 2 shows the results of the viability assay after 24 h of treatment. 
The cytotoxic effect of EPA weakened depending on the oxidation time. EPA, 4 h OEPA, 
8 h OEPA and 16 h OEPA at 30 and 60 µM significantly reduced cell viability to around 
24%, 34%, 34% and 66% of vehicle-treated control cells, respectively. The 24 h OEPA at 
30 µM, but not at 60 µM, had no cytotoxic effect on HepG2 cells under these 
experimental conditions. Notwithstanding, when HepG2 cells were co-incubated with 10 










Figure 2. Effects of EPA and OEPA on cell viability as determined by the water soluble 
tetrazolium (WST)-1 assay. Each fatty acid (30 or 60 μM) was added to HepG2 cells with 
T0901317 (10 nM) and/or vitamin E (10 μM) in serum-free medium containing 0.1% 
BSA. The final ethanol concentration was 0.3%. After 24 h incubation, the WST-1 
solution was added to the cells. The absorbance at 450 nm corresponds to cell viability. 
Expression levels are presented as relative percentage to vehicle control (ethanol). Data 
are reported as means ± SD (n = 4/group). * A significant difference from the vehicle 
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III. OEPA suppresses TG synthesis in HepG2 cells 
While the cells were being treated with each compound, vitamin E was 
simultaneously added in FBS-free medium containing 0.1% BSA since EPA has very 
severe cytotoxic effects, as shown in Figure 2. T0901317 significantly augmented the 
cellular levels of TG after 48 h of incubation. EPA significantly reduced TG synthesis of 
T0901317-treated HepG2 cells. Surprisingly, treatment with OEPA for 4, 8 and 16 h 
significantly inhibited the cellular TG content of HepG2 cells more than did EPA (Fig. 
3). Moreover, the 24 h OEPA, which has around 50% the ion intensity at m/z 301.2 to 
intact EPA (Fig. 1), showed almost the same levels of TG suppression as did intact EPA 
(Fig. 3). These findings indicate that HEPEs might play a crucial role in the effect of 










Figure 3. Effects of EPA and OEPA on TG synthesis in HepG2 cells. Each fatty acid (60 
μM) was added to HepG2 cells with T0901317 (10 nM) and vitamin E (10 μM) as noted 
in serum-free medium containing 0.1% BSA for 48 h. The final ethanol concentration 
was 0.3%. The increased TG levels per mg protein (TG levels after 48 h of incubation 
minus the levels of reference cells) are shown. Data are reported as means ± SD (n = 3-
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IV. OEPA decreases SREBP-1c mRNA expression and maturation more effectively 
than EPA 
The mRNA expression levels of SREBP-1c and SREBP-1 protein levels were 
determined.  The expression of SREBP-1c mRNA in cells treated with 10 nM T0901317, 
a synthetic LXR agonist, was 9.4-fold higher than in vehicle-treated control cells (Fig. 4). 
Treatment with EPA and 4-24 h OEPA significantly down-regulated SREBP-1c mRNA 
expression stimulated by T0901317. In agreement with the result of TG accumulation, 
the suppressive effect of OEPA at 4 and 8 h was statistically stronger than EPA.  The 4 
h OEPA treated cells showed the least SREBP-1c mRNA expression as also noted in the 
effect on TG synthesis in hepatocytes. Furthermore, the 24 h OEPA reduced SREBP-1c 






Figure 4. Effect on SREBP-1c mRNA expression. Each fatty acid (60 μM) was added to 
HepG2 cells with T0901317 (10 nM) and vitamin E (10 μM) as noted in serum-free 
medium containing 0.1% BSA. The final ethanol concentration was 0.3%. After 24 h 
incubation, SREBP-1c mRNA levels were quantified by real-time quantitative PCR. 
Each value of SREBP-1c mRNA was adjusted by that of 18s rRNA (internal control). 
Expression levels are presented as -fold induction relative to the vehicle control (vitamin 
E and ethanol). Data are reported as means ± SD (n = 3/group). Values with different 
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To investigate the effect of these fatty acids on SREBP-1 protein levels, the full-
length precursor form in cell membranes (125 kDa) and the cleaved mature form (68 
kDa) in nuclear extracts were estimated by immunoblotting. Because the antibody used 
cannot distinguish between the SREBP-1c and -1a isoforms, the general term SREBP-1 
was used to refer to the results. Representative blots are shown in Figure 5A and B. 
T0901317 increased the levels of both the precursor and the mature forms of SREBP-1. 
The 4-16 h OEPAs as well as EPA significantly decreased the T0901317 
induction of both the precursor and mature forms of SREBP-1. On the other hand, the 
24 h OEPA significantly differentiated only mature SREBP-1. Corresponding to SREBP-
1c mRNA expression, the precursor form of SREBP-1 was down-regulated by treatment 
with the 4 and 8 h OEPA more significantly than EPA. Interestingly, the mature form of 
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Figure 5. Effects on precursor (A) and mature (B) SREBP-1 protein expression. Each 
fatty acid was added to HepG2 cells with T0901317 (10 nM) and vitamin E (10 μM) as 
noted in serum-free medium containing 0.1% BSA. The final ethanol concentration was 
0.3%. The data represent the mean -fold change of the precursor and the mature forms 
of SREBP-1 from the vehicle control (ethanol). Data are reported as means ± SD (n = 3-
4/group). Values with different letters are significantly different (p < 0.05). 
V. Regulation of mRNA levels of lipogenic genes by OEPA 
Then SREBP-1c target genes and other lipid metabolism related genes were 
examined. Treatment with EPA or 4 h OEPA significantly decreased the expression of 
Acetyl CoA carboxylase (ACC), Fatty acid synthase (FAS) and Stearoyl-coenzyme A 
desaturase-1 (SCD1) mRNAs (Fig. 6A, B, C). Corresponding to the aforementioned 
results, treatment with 4 h OEPA significantly decreased ACC and FAS expression 
more than the vehicle control while treatment with EPA reduced the expression of these 
genes to the same level as the vehicle control (Fig. 6A, B). Moreover, 4 h OEPA 
treatment significantly down-regulated the T0901317-induced expression of SCD1 more 
than did EPA (Fig. 6C). GPA, an enzyme located in the endoplasmic reticulum and the 
4 h OEPA Intact EPA Control Normal 
(B) Mature SREBP-1 













mitochondrial membrane that is required for TG synthesis in the glycerol phosphate 
pathway, which is regulated by SREBP-1c, was significantly weakened by 4 h OEPA 
compared to LXRα agonist-induced cells, while EPA did not affect the increase of GPA 
induced by T0901317 (Fig. 6D). In agreement with the decreased expression of lipogenic 
target genes of SREBP-1c, mRNA expression levels of ATP-binding cassette transporter 
A1 (ABCA1), the other target gene of LXR that is related to cholesterol transport, was 
significantly decreased by 4 h OEPA, but was not significantly changed by EPA (Fig. 6E). 
It was unexpectedly found that after the 4 h OEPA treatment, the expression of PGC-1β, 
the co-activator of LXRα and the SREBP families, was significantly down-regulated in 
the T0901317-induced group. In contrast, EPA did not affect the expression of PGC-1β 
(Fig. 6F). 
VI. The members of HEPEs contained in EPA oxidation products after autoxidation 
From the results mentioned above, the 4 and 8 h OEPAs, which contain high 
portions of HEPEs (m/z 317.2), showed dominant suppressive effects on the lipogenesis 
pathway in HepG2 hepatic cells induced by the synthetic LXRα agonist among EPA and 
other OEPAs which contain lower portions of HEPEs. For this reason, the standards of 
HEPEs, including 5-, 11- and 18-HEPEs, were utilized to identify the kinds of HEPEs 
that occurred in the autoxidized process by LC-MS. The results showed that 5-, 11- and 
18-HEPEs might be members of HEPEs in OEPA due to their correlate retention time 
between peaks of the standards and HEPEs derivative in 4 h OEPA (Fig. 7A). Based on 
their peak area, 5-HEPE is the major member of HEPEs in 4 h OEPA (25.0%). Besides, 
4 h OEPA also has 11-HEPE and 18-HEPE in the proportion of 14.1% and 12.3%, 
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Figure 6. Effects of EPA and OEPA on the expression of acetyl-CoA carboxylase-1 (ACC; 
A), fatty acid synthase (FAS; B), stearoyl-coenzyme A desaturase-1 (SCD-1; C), glycerol-
3-phosphate acyltransferase (GPA; D), ATP-binding cassette sub-family A member 1 
(ABCA1; E) and peroxisome proliferator-activated receptor γ co-activator 1β (PGC-1β; F) 
mRNAs. Each fatty acid (60 μM) was added to HepG2 cells with T0901317 (10 nM) and 
vitamin E (10 μM) as noted in serum-free medium containing 0.1% BSA. The final 
ethanol concentration was 0.3%. After 24 h incubation, ACC, FAS, SCD-1, GPA, ABCA1 
and PGC-1β mRNA levels were quantified by real-time quantitative PCR. Each value of 
ACC, FAS, SCD-1, GPA, ABCA1 and PGC-1β mRNAs was adjusted by that of 18s rRNA 
(internal control). Expression levels are presented as -fold induction relative to the 
vehicle control (vitamin E and ethanol). Data are reported as means ± SD (n = 3/group). 
Values with different letters are significantly different (p < 0.05). 
(A) ACC (B) FAS 
(C) SCD-1 (D) GPA 










































































Figure 7. Various kinds of the standards of HEPEs were compared with HEPEs derived 
from autoxidized EPA.  A: The retention time of 4 h OEPA, 5-HEPE, 11-HEPE, and 18-
HEPE were allegorized. B: Ion intensities percentage of each type of HEPE contained in 
hydroxy EPA (m/z 317.2) derived from 4 h OEPA was measured by using the graph area 
from the specific retention time. Retention time and ion intensities in 4 h OEPA and 
HEPEs were analyzed by LC-MS. 
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VII. Regulation of lipogenic gene mRNA levels by 5-, 11- and 18-HEPEs 
These standard HEPEs were then treated to HepG2 cells to confirm whether 
those HEPEs are involved in the TG reduction of OEPAs. At both 30 and 60 µM 
concentrations, all fatty acids significantly decreased the augmentation of SREBP-1c 
expression caused by the LXRα agonist. It was noteworthy that at a 60 µM 
concentration, 5-HEPE and 18-HEPE significantly reduced SREBP-1c expression more 
than did EPA (Fig. 8A).  The expression of SREBP-1c target genes also had a tendency 
for the same responses. All fatty acids significantly down-regulated the T0901317-
induced increase of ACC. At 30 µM, expression of ACC in the 18-HEPE treated group 
was significantly lower than in the EPA-treated group. In addition, 60 µM 5-HEPE or 
18-HEPE significantly reduced the expression of ACC more than did EPA (Fig. 8B). 
Expression of SCD1 at both 30 µM and 60 µM 18-HEPE was significantly lower than 
was elicited by EPA at similar concentrations (Fig. 8D). On the other hand, all fatty 
acids significantly down-regulated the T0901317-induced expression of FAS, but there 
was no significant different between any of the fatty acids at the same concentrations 
(Fig. 8C). Among all experimental groups, only treatment with 60 µM 18-HEPE 
significantly decreased GPA expression compared with T0901317-stimulated cells. 
Interestingly, cells which were treated with all types of HEPEs in this experiment had 
significantly reduced expression of GPA more than the EPA-treated cells (Fig. 8E). 
Similar to the 4 h OEPA treatment, 18-HEPE at a high dose can significantly decrease 
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Figure 1-11. Effects of EPA, 5-HEPE, 11-HEPE and 18-HEPE on the expression of 
sterol-regulatory element binding protein-1c (SREBP-1c; A), acetyl-CoA carboxylase-1 
(ACC; B), fatty acid synthase (FAS; C), stearoyl-coenzyme A desaturase-1 (SCD-1; D), 
glycerol-3-phosphate acyltransferase (GPA; E) and peroxisome proliferator-activated 
receptor γ coactivator 1β (PGC-1β; F) mRNAs. Each fatty acid (60 μM) was added to 
HepG2 cells with T0901317 (10 nM) and vitamin E (10 μM) as noted in serum-free 
medium containing 0.1% BSA. The final ethanol concentration was 0.3%. After 24 h 
incubation, SREBP-1c, ACC, FAS, SCD-1, GPA and PGC-1β mRNA levels were 
quantified by RT-PCR. The value of each mRNA was adjusted by that of 18s rRNA 
(internal control). Expression levels are presented as -fold induction relative to the 
vehicle control (vitamin E and ethanol). Data are reported as means ± SD (n = 3/group). 
* A significant difference from the T0901317-induced control group (p < 0.05). 
(C) FAS (D) SCD-1 

















































Previous studies showed that oxidation products of EPA and DHA alleviate some 
pathways related to CVD.  In this study, the hypolipidemic effect of OEPA on hepatic 
cells was emphasized. The hypolipidemic effect of PUFAs, including EPA, is attributable 
both to a decrease in lipogenesis and an increase in fatty acid catabolism through the 
regulation of SREBP-1 and PPARα, respectively. Nevertheless, it is well known that 
PPARα weakly expresses and has very low function in HepG2 cells, because the cells are 
originated from hepatoma and some kinds of genes, such as PPARα, is mutated. Thus, 
this study focused on the regulation of lipogenesis via SREBP-1 by OEPA. 
In summary, these data suggest that OEPA augments the ameliorating effect of 
EPA on lipogenesis in liver cells via the suppression of lipogenic genes related to 
SREBP-1c. In addition, the preferable ameliorating effect of OEPA on lipogenesis might 
be due to the decreases of the expressions of PGC-1β and GPA by OEPA, meanwhile 
EPA does not significantly differentiate those expressions (Fig. 1-12). The findings 
provide insight into the importance of the location and the number of hydroxy groups of 
OEPA in the hypolipidemic effect.  This study also suggests that oxidation products as 
food components might contribute to the beneficial effects of EPA on lipid metabolism in 
the liver resulting in the prevention of CVD. However, further in vivo experiments are 
necessary to ensure the effects of dietary OEPA on lipid metabolism. 
Chapter 2: Oxygenated fatty acids fermented by Lactobacillus 
plantarum efficiently decrease TG synthesis in liver 
Oxygenated fatty acids, extracted from intermediates of metabolic pathway of L. 
plantarum, were kindly provided from Dr. Prof. Ogawa (Laboratory of Fermentation 
Physiology and Applied Microbiology, Division of Applied Life Sciences, Graduate School 
of Agriculture, Kyoto University). These oxygenated fatty acids were evaluated to 
HepG2 cells and diabetic KK-Ay mice fed with high fat diet (HFD). Cell viability was 
assessed by WST-1 assay. The mRNA expressions of SREBP-1c and other lipogenic 
genes were evaluated by real-time RT-PCR. The precursor and mature forms of SREBP-
1 protein were fractionated and then examined by western blot analysis. Luciferease 
reporter assay was performed to study LXRα activity. Cellular TG accumulation was 
assayed by Folch’s technique and TG E-test kit. 
Diverse species of oxygenated fatty acids were screened and found that some 
specific species of them, which contains hydroxy or ketone group and some double bonds 
on the same location, prominently decreased SREBP-1c expression among all 
oxygenated fatty acids. Furthermore, these oxygenated fatty acids also statistically 
reduced both forms of SREBP-1c protein expression more than EPA and linoleic acid 
(LA) which is one of their precursors. They suppressed SREBP-1c through the 
regulation of LXRα as similar manner to EPA. These oxygenated fatty acids reduced the 
expression of SCD-1, FAS and ACC1 to almost the same levels with EPA, yet they 
significantly down-regulated ACC2 more than did EPA. Correspondingly, the TG 
accumulations of the groups treated with these oxygenated fatty acids were significantly 
decreased more than did EPA or LA. The results from animal experiment also confirmed 
that these oxygenated fatty acids significantly reduced both forms of SREBP-1 protein 
in the liver of KK-Ay mice fed with HFD. In addition, oxygenated fatty acids containing 
ketone group also significantly decreased mRNA levels of SREBP-1c and ACC2 in the 
liver of those mice. These findings also supported that position and number of hydroxy 
group, ketone group, and double bond in fatty acids might play a crucial role in the 
effect of unsaturated or oxygenated fatty acids on the inhibition of cellular TG synthesis 
in liver cells, especially via SREBP-1c and ACC2 expression in this case. 
Chapter 3: Oxygenated fatty acids fermented by Lactobacillus 
plantarum reduce intracellular lipid accumulation in 3T3-L1 cells 
The oxygenated fatty acids, as mentioned in previous chapter, were treated to 
mouse embryonic fibroblast-adipose like cell line (3T3-L1) with differentiating medium. 
Cell viability was tested by WST-1 assay. The expression of CCAAT/enhancer binding 
protein β (C/EBPβ), C/EBPα, peroxisome proliferator-activated receptor γ (PPARγ) and 
SREBP-1c mRNAs were assessed by real-time RT-PCR. Phosphorylations of Akt were 
assayed by western blot analysis. TG synthesis in adipocytes was evaluated by Oil-red-O 
staining. 
Those oxygenated fatty acids in this study significantly lowered lipid filling of 
differentiated 3T3-L1 cells, while EPA and LA did not. As expected, C/EBPβ 
transcription was significantly down-regulated by most of oxygenated fatty acids used in 
this study at both 30 µM and 60 µM concentrations. PPARγ transcription was decreased 
by all oxygenated fatty acids in this study. On the other hand, only oxo fatty acids can 
reduce the expression of C/EBPα. LA had on effects on the expression of PPARγ and 
C/EBPα in this study. In addition, the phospholyration of Akt after treatment with each 
fatty acid was examined. All fatty acids in this experiment did not differentiate the 
protein expression of pAkt compared with insulin-induced adipocytes. Taken together, 
this chapter proposes that these oxygenated fatty acids suppressed the adipogenesis via 
the down-regulation of C/EBPβ and PPARγ pathway, but not Akt phosphorylation. 
Interestingly, only oxo-fatty acids can down-regulate the expression of C/EBPα, while 
hydroxy-fatty acids, showed no significanct effects. 
 
 
SUMMARY AND CONCLUSION 
It has been concerned that the stability of oxygenated fatty acids from 
autoxidation may be difficult to conserve. Moreover, the oxidized derivatives of EPA 
obtained from autoxidation contain numerous types and are hard to identify and purify 
for future use. In contrast, the fatty acids fermented by the enzymes of L. plantarum 
from fatty acids like linoleic acid, are more stable. In addition, these enzymes change 
the chemical structure at the specific location and function resulting in convenient 
identification and purification. Hence, it is interesting to oxygenate EPA with the 
enzyme of L. plantarum to get more stable and specific types of OEPAs.  
In conclusion, these data suggest that dietary some specific species of oxygenated 
fatty acids could be potently useful as hypolipidemic and anti-obesity agents. The 
advantages of the oxygenated fatty acids in this study are also possible to connect with 
the prevention of many other metabolic and cardiovascular diseases. Furthermore, this 
study also discovered that number, location and type of hydroxy group, ketone group 
and double bond correlate with the efficiency of each fatty acid in lipid metabolism 
regulation. The author believes that this study would provide a significant opportunity 
to develop and utilize oxygenated fatty acids from marine sources for supplement or 
medicinal use. Nevertheless, the oxidation products always develop the worse smell 
than their substrates and it is difficult to relieve this drawback in the real food. 
However, their benefits are also very attractive. Therefore, to utilize them as 
supplement, the technology of capsule can prevent the bad smell to a consumer. In 
addition, using EPA extracted from algae or other sources, instead of fish, may reduce 
the fishy smell even though after oxidation. 
 
 
